Composition for inducing proliferation or accumulation of regulatory T cells
AssigneeThe University of Tokyo
InventorsKenya Honda, Koji Atarashi, Kikuji Itoh, Takeshi Tanoue
Life of this patent
Estimating the term…
Abstract
It was found that bacteria belonging to the genus Clostridium induce accumulation of regulatory T cells (Treg cells) in the colon. Moreover, the present inventors found that regulatory T cells (Treg cells) induced by from these bacteria suppressed proliferation of effector T-cells. From these findings, the present inventors found that the use of bacteria belonging to the genus Clostridium or a physiologically active substance derived therefrom made it possible to induce proliferation or accumulation of regulatory T cells (Treg cells), and further to suppress immune functions.
Claims20
A pharmaceutical composition, comprising six or more live bacterial strains belonging to Clostridium clusters IV and/or XIVa, wherein the six or more bacterial strains induce proliferation and/or accumulation of regulatory T cells, wherein at least one of the bacterial strains is a human commensal bacterial strain, and wherein the pharmaceutical composition is formulated for delivery to the intestine.
Dependencies are inferred from the claim text.